Additionally, adropin was revealed to inhibit SI/R-induced myocardial injury by reducing early myocardial apoptosis, inflammatory response and oxidative stress, and increasing myocardial cell viability
Additionally, adropin was revealed to inhibit SI/R-induced myocardial injury by reducing early myocardial apoptosis, inflammatory response and oxidative stress, and increasing myocardial cell viability. In 2007, Yellon (25) proposed a new cardioprotective strategy to reduce MIRI at the early stages of reperfusion by targeting the RISK-mitochondrial permeability transition pathway (mPTP). decided using western blot analysis….